TOPOFEN Migraine Therapy Phase II Clinical Trial Results

A Phase IIa placebo-controlled clinical trial of TOPOFEN, a topical anti-migraine therapy for moderate and severe migraine sufferers, showed that the application of a well-known non-steroidal anti-inflammatory drug (NSAID) over the trigeminal nerve branches can be a safe and effective alternative treatment for patients suffering from acute migraine. read more

Read the whole article on

More from